You are here: Industry Insights > cancer

News List

Prostate cancer treatment reduced from 37 treatments to 5 europeanpharmaceuticalreview
April 22, 2019
A minimally invasive hydrogel technology was administered, and has previously shown to decrease treatment side effects…
Cardiac monitoring for high-risk breast cancer patients ‘should be prioritised’ europeanpharmaceuticalreview
April 19, 2019
Cardiac monitoring of high-risk breast cancer patients should be prioritised, after research revealed low rates of heart monitoring seen in the patients receiving trastuzumab.
CDC: Recent Decline Seen in High-Grade Cervical Lesions drugs
April 19, 2019
CDC: Recent Decline Seen in High-Grade Cervical Lesions
Some Patients With Imminently Fatal Cancer Undergo Treatment drugs
April 18, 2019
Some patients with imminently fatal de novo metastatic cancer undergo treatment.
New micro-platform improves understanding of cancer cells europeanpharmaceuticalreview
April 18, 2019
A new low-cost, cell culture platform technique may provide insight for more effective cancer treatment, according to the researchers who developed it…
Roche's drugs, new and old, team up for major sales—sans price hikes fiercepharma
April 18, 2019
Last July, Roche put a halt on drug price increases in the U.S. But that didn't stop five of its products from topping analysts' sales estimates by double digits to start the year.
Durvalumab improves survival of non-small cell lung cancer patients europeanpharmaceuticalreview
April 18, 2019
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer…
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale b3cnewswire
April 17, 2019
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale.
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer drugs
April 17, 2019
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer.
FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer drugs
April 17, 2019
FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page